Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
-84.79%
↓ 208% below average
Average (34q)
-27.54%
Historical baseline
Range
High:571.95%
Low:-840.18%
Volatility
-5127.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -84.79% |
| Q2 2025 | 266.37% |
| Q1 2025 | 17.49% |
| Q4 2024 | 73.81% |
| Q3 2024 | -64.38% |
| Q2 2024 | 112.64% |
| Q1 2024 | -90.11% |
| Q4 2023 | 571.95% |
| Q3 2023 | 154.28% |
| Q2 2023 | -346.02% |
| Q1 2023 | 136.73% |
| Q4 2022 | -237.21% |
| Q3 2022 | -10.50% |
| Q2 2022 | 216.61% |
| Q1 2022 | -25.01% |
| Q4 2021 | -6.57% |
| Q3 2021 | -760.04% |
| Q2 2021 | 134.67% |
| Q1 2021 | 45.35% |
| Q4 2020 | -840.18% |
| Q3 2020 | 80.22% |
| Q2 2020 | 25.73% |
| Q1 2020 | -71.96% |
| Q4 2019 | -31.75% |
| Q3 2019 | 17.76% |
| Q2 2019 | 14.24% |
| Q1 2019 | -252.38% |
| Q4 2018 | 189.45% |
| Q3 2018 | 40.28% |
| Q2 2018 | -10.40% |
| Q1 2018 | 12.79% |
| Q4 2017 | -318.22% |
| Q3 2017 | 75.21% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |